Top Tweets for #AASLD
🏆 Four days left to make an impact!
The new #AASLD Impact Award honors members making meaningful contributions across research, clinical care, education, mentorship, and innovation, with a clear trajectory toward future leadership in the field.
Submit a nomination in less than 10 minutes! Self-nominate or nominate a peer before June 7.
👉 Be part of recognizing excellence across the AASLD community, nominate today: https://t.co/pkjTsl0E1V.
📣Calling all early-career women in #hepatology!
The deadline to apply for the #AASLD Women’s Leadership Development Program has been extended to June 26.
Empower your future with this unique opportunity to build leadership skills, connect with senior mentors, and grow your impact in the field.
➡️Take the next step and apply today: https://t.co/nt7wprJzTB
BREAKING NEWS: A major milestone for people living with #HepatitisD.
The FDA has approved #bulevirtide (#Hepcludex), the first approved treatment for chronic #HDV infection.
In this news article, #AASLD member Ira M. Jacobson, MD, FAASLD, highlights the potential of this long-awaited therapy to help address a significant unmet need for people living with HDV.
Read more: https://t.co/b8vcGCgR48.
This #HepatitisAwarenessMonth, Chair of the #AASLD Public Policy Committee, Julius M. Wilder, MD, PhD, FAASLD, highlights a critical message: We have made tremendous progress in #hepatitis screening and treatment, but too many people still remain unscreened.
Continued advocacy, innovation, research funding, and action will be essential to advancing equitable access to care and moving closer to hepatitis elimination.
Learn more about AASLD advocacy and policy efforts: https://t.co/rNqfDwWr9a.
We are pleased to announce 2027 leadership for the #AASLD Governing Board and the @AASLDFoundation Board of Trustees!
Please welcome:
* Meena B. Bansal, MD, FAASLD as Incoming AASLD Councilor (2027-2032) @MeenaBBansal
* Tamar H. Taddei, MD, FAASLD as Incoming AASLD Foundation Chair-Elect (2027), AASLD Foundation Chair (2028-2030)
* Paul Y. Kwo, MD, FAASLD as Incoming AASLD Foundation Trustee (2027-2029) @PaulYKwo
Learn more about each leader: https://t.co/5GDykmulZz
New New New ❗️
Do cardiometabolic risk factors (CMRFs) worsen outcomes in alcohol-associated hepatitis (AH)?
We analyzed 936 hospitalized patients with AH across 14 countries (2015–2024).
#LiverTwitter #Hepatology #ALD #AASLD
Hepatology. 2026.
DOI: 10.1097/HEP.0000000000001780
I am heading to EASL -Barcelona at the end of the month. Anyone else going? #LiverTwitter #AASLD @ebtapper
AASLD brings critical resources and insights to our members to advance #liverdisease research, treatment, and care.
This #HepatitisAwarenessMonth, read, learn, and implement the #AASLD & @IDSAInfo Practice Guideline on the Treatment of Chronic #HepatitisB.
From prevention and maternal transmission to treatment strategies and #livercancer surveillance, get the latest evidence-based recommendations to guide care across every phase of chronic hepatitis B.
📗Online in @HEP_Journal: https://t.co/EqznLgtl1G
Women in #hepatology, if you're ready to grow, connect, and lead, this is your next step!
Through mentorship, tailored learning, and a strong peer network, the #AASLD Women’s Leadership Development Program is designed to help you thrive at the next level.
Take the next step and apply today: https://t.co/nt7wprJzTB
⏳ Up next at #DDW2026
🚨Best of LFN🚨
Saving the best for last ✨
Don’t miss this.
🕓 4:00 – 5:30 PM
📍 W175, McCormick Place
#LiverFellowNetwork #AASLD #Hepatology #GI
Join the Liver Fellow Network at #DDW2026 for a series of engaging sessions designed for trainees and early-career hepatologists.
Bringing together trainees, ideas, and innovation in hepatology 🤝🧬
#LiverFellowNetwork @AASLDtweets #Hepatology #GI @DDWMeeting
Mo2047:Gabapentin use in ALD was associated with:
↑ Alcohol remission (HR 1.29)
↓ Hepatic decompensation (HR 0.79)
In a large TriNetX cohort, Gabapentin also showed a favorable hepatic safety profile.
#DDW2026 #LiverTwitter #AASLD
@AmerGastroAssn
🚨 10:00 AM TODAY | #DDW2026
LFN + PH SIG Present:
Serum & Imaging Biomarkers Driving Liver Disease - Moving Beyond Biopsy
From cutting-edge biomarkers to real-world clinical application 👀
See you there 🔥
📍 W175, McCormick Place
#AASLD #Hepatology @AASLDtweets
Join the Liver Fellow Network at #DDW2026 for a series of engaging sessions designed for trainees and early-career hepatologists.
Bringing together trainees, ideas, and innovation in hepatology 🤝🧬
#LiverFellowNetwork @AASLDtweets #Hepatology #GI @DDWMeeting
Stay connected to the latest in #hepatology, without searching for it.
The #AASLD Publications Showcase page on LinkedIn brings together curated highlights from @HEP_Journal, @LTxJournal, and @HepCommJournal, making it easy to stay current on the science driving the field.
Follow along to quickly connect research to clinical impact and join the conversation with experts across hepatology.
👉 https://t.co/NqnqNDA9xj
📣 Calling all women in #hepatology!
Applications for the 2026 #AASLD Women’s Leadership Development Program are now open.
Empower your future with this unique opportunity to build leadership skills, connect with senior mentors, and grow your impact in the field.
Learn more about the program and apply by Friday, May 29.
👉 https://t.co/nt7wprJzTB
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
240.1M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
108.7M followers
Narendra Modi
@narendramodi
106.9M followers
Rihanna
@rihanna
97.2M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.5M followers
KATY PERRY
@katyperry
86.7M followers
Taylor Swift
@taylorswift13
80.5M followers
Lady Gaga
@ladygaga
72.1M followers
Kim Kardashian
@kimkardashian
69.3M followers
YouTube
@youtube
68.6M followers
Virat Kohli
@imvkohli
68.4M followers
Bill Gates
@billgates
63.3M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
60.9M followers
X
@x
60.9M followers
CNN Breaking News
@cnnbrk
59.9M followers